checkAd

     189  0 Kommentare Ascendis Pharma to Participate in the 42nd Annual J.P. Morgan Healthcare Conference - Seite 2

    Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo and TransCon are trademarks owned by the Ascendis Pharma group. December 2023 Ascendis Pharma A/S.

    Investor Contacts:
    Tim Lee
    Ascendis Pharma
    +1 (650) 374-6343
    tle@ascendispharma.com
    ir@ascendispharma.com

    		 Media Contact:
    Melinda Baker
    Ascendis Pharma
    +1 (650) 709-8875
    media@ascendispharma.com
    Patti Bank
    ICR Westwicke
    +1 (415) 513-1284
    patti.bank@westwicke.com     		 

    Lesen Sie auch


    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Ascendis Pharma to Participate in the 42nd Annual J.P. Morgan Healthcare Conference - Seite 2 COPENHAGEN, Denmark, Dec. 28, 2023 (GLOBE NEWSWIRE) - Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President & Chief Executive Officer, Scott Smith, Executive Vice President & Chief Financial Officer, and Kennett Sprogøe, …